https://doi.org/10.4081/reumatismo.2023.1539
Eosinophilic fasciitis in a young male auto mechanic exposed to organic solvents
Submitted: 1 December 2022
Accepted: 8 July 2023
Published: 18 September 2023
Accepted: 8 July 2023
Abstract Views: 945
PDF: 333
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
We report a case of eosinophilic fasciitis in a teenage auto mechanic who was most likely affected by occupational exposure to organic solvents, including the aromatic hydrocarbons benzene, trimethylbenzene, naphthalene, toluene, and xylene. The patient presented with an 8-month history of painful induration of his extremities and an abnormal gait. A deep excisional biopsy of the fascia was obtained, demonstrating subcutaneous fibrosis with perivascular and interstitial inflammation, with lymphocytes and plasma cells spilling into the sclerosed fascia, and focal fibrinoid necrosis. Treatment was begun with intravenous pulse doses of methylprednisolone, prednisone (20 mg daily), and subcutaneous methotrexate (25 mg weekly), and the patient’s painful induration had resolved and gait had normalized at the 6-month follow-up. Our case suggests that exposure to organic solvents could be implicated in the pathogenesis of eosinophilic fasciitis and highlights the importance of a thorough occupational history to prevent repeat exposures to potentially causative agents.
Mazori DR, Femia AN, Vleugels RA. Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep 2017; 19: 74.
DOI: https://doi.org/10.1007/s11926-017-0700-6
Pinal-Fernandez I, Selva-O' Callaghan A, Grau JM. Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev 2014; 13: 379-82.
DOI: https://doi.org/10.1016/j.autrev.2014.01.019
Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol 2008; 47: 29-35.
DOI: https://doi.org/10.1111/j.1365-4632.2007.03544.x
Pinal-Fernandez I, Callejas-Moraga EL, Roade-Tato ML, Simeon-Aznar CP. Groove sign in eosinophilic fasciitis. Lancet 2014; 384: 1774.
DOI: https://doi.org/10.1016/S0140-6736(14)60526-2
Jinnin M, Yamamoto T, Asano Y, Ishikawa O, Sato S, Takehara K, et al. Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis. J Dermatol 2018; 45: 881-90.
DOI: https://doi.org/10.1111/1346-8138.14160
Barragan-Martinez C, Speck-Hernandez CA, Montoya-Ortiz G, Mantilla RD, Anaya JM, Rojas-Villarraga A. Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PLoS One 2012; 7: e51506.
DOI: https://doi.org/10.1371/journal.pone.0051506
Ouchene L, Muntyanu A, Lavoue J, Baron M, Litvinov IV, Netchiporouk E. Toward understanding of environmental risk factors in systemic sclerosis [formula: see text]. J Cutan Med Surg 2021; 25: 188-204.
DOI: https://doi.org/10.1177/1203475420957950
Ohtsuka T. Organic solvent-induced myopathy simulating eosinophilic fasciitis and/or dermatomyositis. J Dermatol 2009; 36: 358-9.
DOI: https://doi.org/10.1111/j.1346-8138.2009.00653.x
Wang G, Cai P, Ansari GA, Khan MF. Oxidative and nitrosative stress in trichloroethene-mediated autoimmune response. Toxicology 2007; 229: 186-93.
DOI: https://doi.org/10.1016/j.tox.2006.10.014
Uzma N, Salar BM, Kumar BS, Aziz N, David MA, Reddy VD. Impact of organic solvents and environmental pollutants on the physiological function in petrol filling workers. Int J Environ Res Public Health 2008; 5: 139-46.
DOI: https://doi.org/10.3390/ijerph5030139
Lebeaux D, Frances C, Barete S, Wechsler B, Dubourg O, Renoux J, et al. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology 2012; 51: 557-61.
DOI: https://doi.org/10.1093/rheumatology/ker366
How to Cite
Treichel, A., Zheng, D., Ranasinghe, G., Zeft, A., Bergfeld, W., & Bayart, C. (2023). Eosinophilic fasciitis in a young male auto mechanic exposed to organic solvents. Reumatismo, 75(3). https://doi.org/10.4081/reumatismo.2023.1539
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi, Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis , Reumatismo: Vol. 61 No. 1 (2009)
- C. Tani, M. Mosca, A. d'Ascanio, R. Neri, A. Tavoni, L. Carli, S. Bombardieri, Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide , Reumatismo: Vol. 62 No. 3 (2010)
- M. Bellan, S. Bor, A. Gibbin, A. Gualerzi, S. Favretto, G. Guaschino, R. Bonometti, A. Rossini, D. Sola, R. Pedrazzoli, G.P. Carnevale Schianca, M. Pirisi, P.P. Sainaghi, Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis , Reumatismo: Vol. 70 No. 4 (2018)
- F. Ceccarelli, V. Covelli, G. Olivieri, F. Natalucci, C. Alessandri, F. Conti, Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study , Reumatismo: Vol. 74 No. 2 (2022)
- A. Martins, S. Ganhão, F. Aguiar, M. Rodrigues, I. Brito, Predictors of poor outcomes in juvenile dermatomyositis: what do we know? A narrative review , Reumatismo: Early Access
- N. Franzolini, L. Quartuccio, G. De Marchi, S. De Vita, Efficacy of immunosoppressive therapy and steroid sparing effect in interstitial lung disease associated to antisynthetase syndrome , Reumatismo: Vol. 59 No. 3 (2007)
- R. Herrera-Esparza, E. Avalos-Diaz, Infliximab treatment in a case of rheumatoid scleromalacia perforans , Reumatismo: Vol. 61 No. 3 (2009)
- M. Amatruda, N.S. Carucci, C. Fede, G. Conti, Subclinical TRAPS treated with canakinumab , Reumatismo: Vol. 73 No. 2 (2021)
- C.A. Scirè, R. Caporali, C. Perotti, C. Montecucco, Plasma procalcitonin in rheumatic diseases , Reumatismo: Vol. 55 No. 2 (2003)
- S. Zingarelli, P. Airò, M. Frassi, C. Bazzani, M. Scarsi, M. Puoti, Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases , Reumatismo: Vol. 60 No. 1 (2008)
<< < 19 20 21 22 23 24 25 26 27 > >>
You may also start an advanced similarity search for this article.
